OWC Pharmaceutical Research Corp (OWCP)

[moxa1]

Once they announce the results of the safety trials (hopefully published results) the pps will be much higher than it is now and so will the base. If they were to announce a JV/partnership for the cream the pps will be even higher. After that we still have the sublingual tablets and PTSD as well as other uses for the cream, then the MM study and an application for fast track status. Don't forget cross listing to the TSX at some point when we are eligible too. Your scenario of us dropping down to $.30 or $.40 in 2018 isn't realistic IMO. They could announce the cream coming to market in Germany, Canada, California and elsewhere too. We will be looking a dollars, not centavos!